Hyperfine (HYPR) Competitors $1.46 -0.06 (-3.95%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$1.48 +0.02 (+1.23%) As of 08:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. SMLR, CBLL, BFLY, CARL, RXST, DCTH, NPCE, DRTS, SKIN, and SNWVShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Carlsmed (CARL), RxSight (RXST), Delcath Systems (DCTH), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Beauty Health (SKIN), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors Semler Scientific CeriBell Butterfly Network Carlsmed RxSight Delcath Systems NeuroPace Alpha Tau Medical Beauty Health Sanuwave Health Hyperfine (NASDAQ:HYPR) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Do analysts prefer HYPR or SMLR? Hyperfine presently has a consensus price target of $1.28, indicating a potential downside of 12.10%. Semler Scientific has a consensus price target of $74.25, indicating a potential upside of 145.78%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, HYPR or SMLR? Semler Scientific has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHyperfine$12.89M8.90-$40.72M-$0.52-2.81Semler Scientific$56.29M7.95$40.90M$2.4312.43 Do insiders and institutionals believe in HYPR or SMLR? 15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 31.0% of Hyperfine shares are owned by company insiders. Comparatively, 16.4% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is HYPR or SMLR more profitable? Semler Scientific has a net margin of 86.20% compared to Hyperfine's net margin of -364.54%. Semler Scientific's return on equity of 43.84% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Hyperfine-364.54% -84.82% -69.39% Semler Scientific 86.20%43.84%32.88% Which has more volatility and risk, HYPR or SMLR? Hyperfine has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Does the media prefer HYPR or SMLR? In the previous week, Semler Scientific had 49 more articles in the media than Hyperfine. MarketBeat recorded 50 mentions for Semler Scientific and 1 mentions for Hyperfine. Hyperfine's average media sentiment score of 1.89 beat Semler Scientific's score of 0.20 indicating that Hyperfine is being referred to more favorably in the media. Company Overall Sentiment Hyperfine Very Positive Semler Scientific Neutral SummarySemler Scientific beats Hyperfine on 13 of the 16 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$119.44M$6.74B$5.74B$10.39BDividend YieldN/A1.22%5.75%4.64%P/E Ratio-2.8125.0375.9526.11Price / Sales8.90196.58546.83124.93Price / CashN/A21.5437.5461.24Price / Book2.185.0112.666.30Net Income-$40.72M$178.07M$3.29B$271.03M7 Day Performance0.69%-0.74%0.25%-0.20%1 Month Performance15.87%5.20%2.80%5.77%1 Year Performance39.05%21.95%63.42%27.62% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine1.6091 of 5 stars$1.46-3.9%$1.28-12.1%+40.4%$119.44M$12.89M-2.81190Positive NewsSMLRSemler Scientific2.8296 of 5 stars$28.39-2.7%$81.75+188.0%+33.3%$432.16M$42.98M11.68120Trending NewsAnalyst ForecastGap DownCBLLCeriBell2.0849 of 5 stars$11.95+3.3%$32.14+169.0%N/A$424.20M$65.44M-4.00N/ABFLYButterfly Network3.2542 of 5 stars$1.66+5.4%$3.00+81.3%+26.9%$395.23M$82.06M-5.91460Gap DownCARLCarlsmedN/A$14.65-0.9%N/AN/A$393.14M$27.17M0.00100Positive NewsRXSTRxSight1.6203 of 5 stars$9.23-0.9%$10.00+8.3%-81.5%$380.93M$139.93M-11.54220DCTHDelcath Systems2.5703 of 5 stars$10.67-1.6%$24.50+129.6%+20.8%$379.20M$37.21M213.4060Positive NewsNPCENeuroPace3.3307 of 5 stars$9.82-0.4%$16.60+69.0%+49.2%$326.18M$79.91M-11.69170Positive NewsDRTSAlpha Tau Medical2.2928 of 5 stars$3.85+1.0%$9.00+133.8%+79.3%$323.16MN/A-8.0280SKINBeauty Health1.9535 of 5 stars$2.63+4.0%$2.63-0.2%+47.0%$320.87M$334.30M-9.391,030Positive NewsHigh Trading VolumeSNWVSanuwave Health2.1094 of 5 stars$35.57-3.8%$55.00+54.6%N/A$316.85M$32.63M-4.3140 Related Companies and Tools Related Companies Semler Scientific Alternatives CeriBell Alternatives Butterfly Network Alternatives Carlsmed Alternatives RxSight Alternatives Delcath Systems Alternatives NeuroPace Alternatives Alpha Tau Medical Alternatives Beauty Health Alternatives Sanuwave Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HYPR Stock Alerts